Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avis Budget

104.13
+3.043.01%
Post-market: 104.210.0800+0.08%19:41 EDT
Volume:1.98M
Turnover:207.13M
Market Cap:3.66B
PE:-1.67
High:107.10
Open:102.11
Low:101.74
Close:101.09
Loading ...

Why Black Cat, CAR Group, Data#3, and Helia shares are falling today

MotleyFool
·
14 Mar

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

GlobeNewswire
·
14 Mar

Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

GlobeNewswire
·
14 Mar

Avis Could Benefit If Tariffs Raise Car Prices -- Market Talk

Dow Jones
·
14 Mar

Why Is Avis Budget (CAR) Down 25.1% Since Last Earnings Report?

Zacks
·
13 Mar

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses

ACCESS Newswire
·
13 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney

Reuters
·
12 Mar

BUZZ-US travel-related shares tumble as airline forecasts fuel concerns

Reuters
·
12 Mar

CAR's Stock Drop Lures Returning Bull -- Market Talk

Dow Jones
·
11 Mar

2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

Business Wire
·
11 Mar

Press Release: Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
11 Mar

Avis Budget put volume heavy and directionally bearish

TIPRANKS
·
11 Mar

Q3 2025 America's CAR-MART Inc Earnings Call

Thomson Reuters StreetEvents
·
07 Mar

CAR Group (WN6) Gets a Buy from Citi

TIPRANKS
·
07 Mar

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

Business Wire
·
07 Mar

Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

GlobeNewswire
·
06 Mar

Winners And Losers Of Q3: Heartland Express (NASDAQ:HTLD) Vs The Rest Of The Ground Transportation Stocks

StockStory
·
05 Mar

Minority investor says UOI is over-capitalised, and should distribute Haw Par as dividend-in-specie

The Edge Singapore
·
28 Feb

ImmunityBio Receives FDA RMAT Designation for ANKTIVA® and CAR-NK for the Reversal of Lymphopenia in Patients Receiving Standard-of-Care Chemotherapy/Radiotherapy and in Treatment of Multiply Relapsed Locally Advanced or Metastatic Pancreatic Cancer

Business Wire
·
28 Feb

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)

Business Wire
·
27 Feb